Evidence map›Paper›PMID 25590339›Full record

ReviewRNA biology2014

RNA-guided isomerization of uridine to pseudouridine--pseudouridylation.

Yi-Tao Yu, U Thomas Meier

Open access · bronzeAbstract readReview
In one paragraph

Review in RNA biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 135 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Archaeal RNA processing and regulation: expanding the functional landscape.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Small nucleolar RNAs: the hidden precursors of cancer ribosomes.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yi-Tao Yua University of Rochester Medical Center; Department of Biochemistry and Biophysics ; Center for RNA Biology ; Rochester , NY USA.
U Thomas Meier
Albert Einstein College of Medicine · USUniversity of Rochester Medical Center · US

Funding

Biogenesis of H/ACA RibonucleoproteinsR01GM097752 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI MEIER, U THOMAS · 2012 to 2015
$1.3M
Expanding the genetic code by targeted pseudouridylationR01GM104077 · NIGMS · UNIVERSITY OF ROCHESTER · PI YU, YI-TAO · 2012 to 2015
$1.2M
Regulation of telomerase activity and aging by 2'-O-methylation in telomerase RNAR21AG039559 · NIA · UNIVERSITY OF ROCHESTER · PI YU, YI-TAO · 2012 to 2013
$412k
NIA NIH HHS AG039559NIGMS NIH HHS GM097752NIGMS NIH HHS GM104077NIGMS NIH HHS R01 GM097752NIGMS NIH HHS R01 GM104077
6 · The paper itself

Abstract

Box H/ACA ribonucleoproteins (RNPs), each consisting of one unique guide RNA and 4 common core proteins, constitute a family of complex enzymes that catalyze, in an RNA-guided manner, the isomerization of uridines to pseudouridines (Ψs) in RNAs, a reaction known as pseudouridylation. Over the years, box H/ACA RNPs have been extensively studied revealing many important aspects of these RNA modifying machines. In this review, we focus on the composition, structure, and biogenesis of H/ACA RNPs. We explain the mechanism of how this enzyme family recognizes and specifies its target uridine in a substrate RNA. We discuss the substrates of box H/ACA RNPs, focusing on rRNA (rRNA) and spliceosomal small nuclear RNA (snRNA). We describe the modification product Ψ and its contribution to RNA function. Finally, we consider possible mechanisms of the bone marrow failure syndrome dyskeratosis congenita and of prostate and other cancers linked to mutations in H/ACA RNPs.

Indexed as

RNA Processing, Post-TranscriptionalDyskeratosis CongenitaHumansIsomerismMaleMutationNucleic Acid ConformationProstatic NeoplasmsPseudouridineRibonucleoproteins, Small NuclearRNA, Guide, CRISPR-Cas SystemsRNA, RibosomalRNA, Small NuclearRNA, Transfer, Amino Acid-SpecificUridinePseudouridineRibonucleoproteins, Small NuclearRNA, Guide, CRISPR-Cas SystemsRNA, RibosomalRNA, Small NuclearRNA, Transfer, Amino Acid-SpecificUridineDC, dyskeratosis congenitadyskeratosis congenitaH/ACAHH, hoyeraal-hreidarsson syndromePIKK, phosphatidylinositol 3-kinase-related kinaseprostate cancerpseudouridinePUA, pseudouridylase and archaeosine transglycosylaseribonucleoproteinsRNA-guidedRNA modificationRNP, ribonucleoproteinrRNArRNA, ribosomal RNAsca, small Cajal bodySMN, survival of motor neuron proteinsnoRNAsnoRNA, small nucleolar RNAsno, small nucleolarsnRNA, small nuclear RNAspliceosomal small nuclear RNASSD, SHQ1 specific domaintRNA, transfer RNAU, uridineX-DC, X-linked dyskeratosis congenitaψ, pseudouridine, 5-ribosyluracil

Identifiers

PMID25590339
PMCPMC4615163
OpenAlexW2019427404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.